ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-OR042

Association of Dietary Magnesium (Mg2+) and Potassium (K+) Intake with Mortality and Kidney Failure in the CRIC Study

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Gillis, Margaret, Tufts Medical Center, Boston, Massachusetts, United States
  • Tighiouart, Hocine, Tufts Medical Center, Boston, Massachusetts, United States
  • Reaves, Allison Cook, Tufts Medical Center, Boston, Massachusetts, United States
  • Drew, David A., Tufts Medical Center, Boston, Massachusetts, United States
Background

Increased intake of Mg2+ and K+ are each linked to lower risk of cardiovascular outcomes and death. While studies have shown improved kidney outcomes with increased dietary intake of Mg2+ or K+, data is limited in CKD patients.

Methods

Using Chronic Renal Insufficiency Cohort data, we included subjects with baseline dietary surveys and a follow up measure of eGFR (n = 3318). Estimated daily Mg2+ (including supplemental) and K+ intake were examined as predictors for subsequent death or kidney failure*. Our final statistical model^ was repeated and stratified into groups of eGFR < 30 and ≥ 30 ml/min.

Results

The median intake (mg/day) was 312 for Mg2+ and 2636 for K+. Higher Mg2+ and K+ intake were associated with a lower risk for death (Fig 1 a&c). Stratified analyses showed a similar relationship regardless of eGFR group (Fig 2 a&c). Mg2+ or K+ intake had no consistent relationship with kidney failure in the total cohort (Fig 1 b&d), but each appeared protective for kidney failure only in the eGFR ≥ 30 ml/min subgroup (Fig 2 b&d).

Conclusion

Our data suggest Mg2+ and K+ intake are protective against death in CKD patients, regardless of degree of kidney disease. While not statistically significant in all models, our data also suggest both Mg2+ and K+ intake may be protective against kidney failure, but only in those with an eGFR ≥ 30 ml/min. Future research should study the benefits or potential harms of Mg2+ and/or K+ supplementation in CKD patients.

Digital Object Identifier (DOI)